Proxy Materials

AbCellera Biologics Inc. Filed 2021-04-28 Acc 0001140361-21-014741

Documents 1

2022-04-28 DEFA14A Proxy Materials
2021-04-28 DEFA14A Proxy Materials
2021-04-28 DEF 14A Proxy Statement
2021-04-23 4 Chief Technology Officer acquired 1,000,000 shares (option exercise)

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading nc10023167x2_defa14a.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…